<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Hoyle, Brian</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">McIntyre, Roger S.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Vortioxetine Improves Cognitive Function, Lessens Symptoms of Major Depression</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-06-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">14-15</style></pages><abstract><style  face="normal" font="default" size="100%">A multinational, randomized, double-blind, placebo-controlled Efficacy Study of Vortioxetine on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder (MDD) [FOCUS; NCT01422213] has demonstrated the drug's efficacy in improving cognitive function and lessening depression symptoms [APA 2014 (poster NR6-114)].</style></abstract><number><style face="normal" font="default" size="100%">8</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>